Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Zhijie Dai"'
Publikováno v:
Journal of Materials Research and Technology, Vol 31, Iss , Pp 1036-1043 (2024)
The increase in the mechanical performance of Al–Cu alloys through TiC particle reinforcement represents a significant improvement in the field of aluminum alloy strengthening. However, the precipitation behavior at the aluminum matrix and TiC inte
Externí odkaz:
https://doaj.org/article/e0facb9bd99d423e8e1dec124ab263d5
Autor:
Zhijie Dai, Ronghua Zhu, Zhifeng Sheng, Guijun Qin, Xianghang Luo, Qun Qin, Chunli Song, Liping Li, Ping Jin, Guoping Yang, Yanxiang Cheng, Danhong Peng, Chong Zou, Lijuan Wang, Jianzhong Shentu, Qin Zhang, Zhe Zhang, Xiang Yan, Pingfei Fang, Qiangyong Yan, Lingfeng Yang, Xiao Fan, Wei Liu, Bo Wu, Rongrong Cui, Xiyu Wu, Yuting Xie, Chang Shu, Kai Shen, Wenhua Wei, Wei Lu, Hong Chen, Zhiguang Zhou
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
SHR-1222, a novel humanized monoclonal antibody targeting sclerostin, has been shown to induce bone formation and decrease bone resorption at a single dose ranging 50–400 mg in our previous phase 1 trial. This study was a randomized, double-blind,
Externí odkaz:
https://doaj.org/article/a89e55f5717f475a9a05befd69d69692
Autor:
Xin Li, Shengdan Nie, Ziyang Lv, Lingran Ma, Yuxi Song, Zhongxu Hu, Xin Hu, Zhiqiang Liu, Gaoya Zhou, Zhijie Dai, Tao Song, Jiajia Liu, Shan Wang
Publikováno v:
Cell Death and Disease, Vol 12, Iss 3, Pp 1-13 (2021)
Abstract In order to set up a reliable prediction system for the tumor grade and prognosis in glioma patients, we clarify the complicated crosstalk of Annexin A2 (ANXA2) with Glypican 1 (GPC1) and demonstrate whether combined indexes of ANXA2 and GPC
Externí odkaz:
https://doaj.org/article/7471e8b909f24d109edb01aaa733895e
Autor:
Zhijie Dai, Pingfei Fang, Xiang Yan, Ronghua Zhu, Qiong Feng, Qiangyong Yan, Lingfeng Yang, Xiao Fan, Yuting Xie, Lihong Zhuang, Sheng Feng, Yantao Liu, Sheng Zhong, Zeyu Yang, Zhifeng Sheng, Zhiguang Zhou
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
SHR-1222 is a humanized monoclonal antibody targeting sclerostin and has the potential to promote bone formation and reduce bone resorption. This study was aimed to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenici
Externí odkaz:
https://doaj.org/article/6c64f672c30c4cd99d58bfd8e8ae0bc5
Publikováno v:
Journal of Immunology Research, Vol 2016 (2016)
Background. Fulminant type 1 diabetes (FT1D) is a novel subtype of type 1 diabetes characterized by extremely rapid onset and complete deficiency of insulin due to the destruction of pancreatic β cells. However, the precise mechanisms underlying the
Externí odkaz:
https://doaj.org/article/b6f0fc7d46fd49a7a197c365d3c35388
Autor:
Zhijie Dai, Ronghua Zhu, Zhifeng Sheng, Guijun Qin, Xianghang Luo, Qun Qin, Chunli Song, Liping Li, Ping Jin, Guoping Yang, Yanxiang Cheng, Danhong Peng, Chong Zou, Lijuan Wang, Jianzhong Shentu, Qin Zhang, Zhe Zhang, Xiang Yan, Pingfei Fang, Qiangyong Yan
Publikováno v:
Frontiers in Endocrinology; 4/5/2023, Vol. 14, p1-13, 13p
Publikováno v:
Journal of Cancer
Purpose: Advanced epithelial ovarian cancer (EOC) eventually develops into a recurrent platinum-resistant disease. The response to standard treatment and prognosis in patients with EOC is generally unsatisfactory. This study aimed to assess the effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1367fc245edb66a5d7eb73e5e06e8a79
https://doi.org/10.7150/jca.45547
https://doi.org/10.7150/jca.45547
Autor:
Sheng Zhong, Lingfeng Yang, Zhifeng Sheng, Yuting Xie, Ping-Fei Fang, Sheng Feng, Qiong Feng, Qiangyong Yan, Yantao Liu, Zhijie Dai, Zhiguang Zhou, Rong-Hua Zhu, Xiang Yan, Xiao Fan, Lihong Zhuang, Zeyu Yang
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology
Frontiers in Pharmacology
SHR-1222 is a humanized monoclonal antibody targeting sclerostin and has the potential to promote bone formation and reduce bone resorption. This study was aimed to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ccdfe43a5e395b0eb2c4d330a43b447
https://doi.org/10.3389/fphar.2021.770073
https://doi.org/10.3389/fphar.2021.770073
Autor:
Xin Li, Shengdan Nie, Ziyang Lv, Lingran Ma, Yuxi Song, Zhongxu Hu, Xin Hu, Zhiqiang Liu, Gaoya Zhou, Zhijie Dai, Jiajia Liu, Tao Song, Shan Wang
Background: Glioma, with varying malignancy grades, is the most common primary brain tumor. It is urgent to set up a reliable prediction system for the tumor grade and prognosis in glioma patients. We aimed to clarify the complicated crosstalk of Ann
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be6f4e76202ef77ca83c7943ed6ec5cd
https://doi.org/10.21203/rs.3.rs-56818/v1
https://doi.org/10.21203/rs.3.rs-56818/v1
Publikováno v:
Investigational new drugs. 38(6)
Naringenin (NG) is a natural antioxidant flavonoid which is isolated from citrus fruits, and has been reported to inhibit colon cancer proliferation. However, the effects of NG treatment on glioma remain to be elucidated. The present study aimed to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7707cf301474030c2624186e7572d925
https://pubmed.ncbi.nlm.nih.gov/32767162
https://pubmed.ncbi.nlm.nih.gov/32767162